Relmada Therapeutics, Inc. (RLMD)
RLMD Swing Trading Playbook - May 30, 2026 Current Price Range ~$7.21 – $7.36 ▲ After-Hours +2% Previous Close $7.21 (-0.55%) Assessment Date May 30, 2026 Relmada Therapeutics, Inc. (RLMD) is a clinical-stage biotech focused on developing novel therapies for central nervous system disorders and oncology. Lead candidate NDV-01 (sustained-release gemcitabine/docetaxel) is advancing toward Phase 3 for non-muscle invasive bladder cancer. The company also has sepranolone in development for compulsive disorders and Prader-Willi syndrome. Cash runway extends into 2029 (~$234M). Swing Trade Scenarios & Risk Profiles Scenario Entry Point Stop-Loss Target(s) Potential Return R:R Ratio Est. Prob. Strategic Notes Bullish ...